Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

Auteurs

Cyrille Hulin, Fritz Offner, Philippe Moreau, Murielle Roussel, Karim Belhadj, Lotfi Benboubker, Denis Caillot, Thierry Facon, Laurent Garderet, Frédérique Kuhnowski, Anne-Marie Stoppa, Brigitte Kolb, Mourad Tiab, Kon-Siong Jie, Matthijs Westerman, Jérôme Lambert, Lixia Pei, Veronique Vanquickelberghe, Carla De Boer, Jessica Vermeulen, Tobias Kampfenkel, Pieter Sonneveld, Niels W.C.J. Van de Donk